ArticleEndocrine2021
The efficacy and safety of microwave ablation versus lobectomy for the treatment of benign thyroid nodules greater than 4 cm.
Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules.Endocrine, metabolic & immune disorders drug targets · 2023Guideline
- The efficacy and safety of microwave ablation in benign large thyroid nodules (≥4 cm).European thyroid journal · 2026Article
- Implementing Ultrasound-Guided Microwave Ablation for Benign Thyroid Nodules in ENT Practice: Technical Considerations and Early Clinical Experience.Journal of clinical medicine · 2026Article
- Efficacy of microwave ablation in the treatment of large benign thyroid nodules: a multi-center study.European radiology · 2024Article
- Incomplete ablation of thyroid cancer: Achilles' Heel?BMC endocrine disorders · 2024Article
- Development and preclinical evaluation of multifunctional hydrogel for precise thermal protection during thermal ablation.Bioactive materials · 2024Article
- Value of CEUS combined with feeding artery ablation in the microwave ablation of large solid benign thyroid nodules.European radiology · 2023Article
- Long-term outcome of microwave ablation for benign thyroid nodules: Over 48-month follow-up study.Frontiers in endocrinology · 2022Article
- Efficacy and safety of ultrasound-guided microwave ablation versus surgical resection for Bethesda category IV thyroid nodules: A retrospective comparative study.Frontiers in endocrinology · 2022Article
- Continuous, Large-Volume Hydrodissection to Protect Delicate Structures around the Thyroid throughout the Radiofrequency Ablation Procedure.European thyroid journal · 2021Article
- Conspicuousness and recurrence related factors of ultrasound-guided microwave ablation in the treatment of benign thyroid nodules.BMC surgery · 2021Article
- Ablating Aspiration Needle Tract Prior to Microwave Ablation Can Improve Therapeutic Outcomes for Predominantly Cystic Thyroid Nodules.Frontiers in endocrinology · 2021Article
- Ultrasound-guided microwave ablation of benign thyroid nodules: effects on inflammatory factors and thyroid function.American journal of translational research · 2021Article
- Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study.Frontiers in endocrinology · 2021Article
- Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?Cancer management and research · 2020Review
- Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma.Frontiers in oncology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
purposeTo evaluate the safety and effectiveness of microwave ablation (MWA) versus lobectomy for the treatment of benign thyroid nodules > 4 cm.
methodsWe retrospectively analyzed the data of 48 patients who underwent MWA and 53 patients who underwent lobectomy to treat benign thyroid nodules > 4 cm. The patients were followed up for 12 months. The volume reduction ratio (VRR) was calculated. The operation time, incision length, hospitalization time, complications, thyroid function, symptoms, and cosmetic improvement were analyzed and compared between the two groups.
resultsDuring the 12-month follow-up, the mean nodule volume in the MWA group was reduced from 36.1 ± 23.1 to 4.0 ± 4.1 ml, and the mean VRR of the nodules was 90 ± 5% in the MWA group, which was comparable with that in the surgery group. No significant postoperative change in thyroid function was observed in the MWA group. Compared with the surgery group, the incidence of complications and postoperative pain in the MWA group were lower, the operation time, incision length, and hospitalization time in the MWA group were shorter, and satisfaction with the esthetic results in the MWA group was greater.
conclusionMWA is safe and effective for the treatment of benign thyroid nodules > 4 cm. Moreover, MWA is associated with a faster recovery, fewer complications, better protection of thyroid function, and superior esthetic results relative to thyroid lobectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.